ClinicalTrials.Veeva

Menu

Assessment of Anterior Cruciate Ligament (ACL) Degeneratio Mucosa Treatment

A

Artromedical Konrad Malinowski Clinic

Status

Enrolling

Conditions

Anterior Cruciate Ligament Injuries

Treatments

Procedure: ACL "decompression"

Study type

Observational

Funder types

Other

Identifiers

NCT05701579
1-pro-ar-2023

Details and patient eligibility

About

Anterior Cruciate Ligament (ACL) Degeneratio Mucosa is a condition resulting from mucoid degeneration of ACL. Exact etiology is unknown, however ACL Degeneratio Mucosa impairs everyday functioning. In the literature there were some reports of treatment by ACL excision and subsequent reconstruction, however such treatment brings risk of deteriorated function. In this study the investigator will evaluate the technique of ACL "decompression" by the means of longitudinal incisions and evacuation of extrafibrous mucoid tissue.

Enrollment

10 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients with ACL degeneratio mucosa decided to undergo a surgical treatment
  • range of motion impairment caused by mucoid or cystic changes in ACL confirmed by MRI

Exclusion criteria

  • non-adherence to the study protocol
  • active knee inflammation
  • range of motion impairment due to other extra- and intra-articular reasons

Trial design

10 participants in 1 patient group

Patients with ACL Degeneratio Mucosa
Description:
Patients with ACL Degeneratio Mucosa
Treatment:
Procedure: ACL "decompression"

Trial contacts and locations

1

Loading...

Central trial contact

Konrad Malinowski, MD PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems